Meme Kanserinde Leptomeningeal Metastaz: Tanı, Tedavi ve Gelecek Perspektifler

Clarke JL, et al. Leptomeningeal metastases in the MRI era. Neurology. 2010.

Franzoi MA, et al. Leptomeningeal carcinomatosis in breast cancer. Crit Rev Oncol Hematol. 2019.

Le Rhun E, et al. Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013.

Boire A, et al. Liquid biopsy in CNS metastases: RANO review. Neuro Oncol. 2019.

Chamberlain MC. Leptomeningeal metastasis. Curr Opin Oncol. 2010.

Bartsch R, et al. Breast cancer brain metastases responding to T-DM1. J Neurooncol. 2014.

Niwińska A, et al. Breast cancer leptomeningeal metastasis: clinical presentation and management. Oncology. 2007.

Glantz MJ, et al. Survival in patients with leptomeningeal metastases. J Neurooncol. 1998.

Chamberlain MC. Neoplastic meningitis. Oncologist. 2008.

Waki F, et al. Prognostic factors and outcomes in leptomeningeal metastasis. J Neurooncol. 2009.

Stemmler HJ, et al. HER2-positive CTCs in metastatic breast cancer. Breast Cancer Res Treat. 2009.

Spector NL, et al. HER2 signaling and targeted therapy. Nat Rev Drug Discov. 2009.

Rexer BN, et al. PI3K pathway in HER2+ breast cancer. Cancer Res. 2013.

Boire A, et al. Adaptation of tumor cells to cerebrospinal fluid. Cell. 2017.

Brastianos PK, et al. Complement component 3 and LM. Nat Med. 2020.

Boire A, et al. CNS immune microenvironment in LM. Nat Rev Clin Oncol. 2020.

Hyun JW, et al. Clinical experience of LM. Eur J Cancer. 2016.

Clarke JL, et al. Neurologic symptoms in LM. Neurol Clin. 2012.

DeAngelis LM. Neurologic complications of cancer. Oxford University Press. 2009.

Wasserstrom WR, et al. Diagnosis of leptomeningeal metastasis. Cancer. 1982.

Chamberlain MC. Comparative spine imaging in LM. J Neurooncol. 1995.

Glantz MJ, et al. CSF immunocytochemistry in LM. J Clin Oncol. 2004.

Chamberlain MC, Sandy AD. Imaging in leptomeningeal disease. Neurology. 1990.

Brandsma D, et al. Clinical features of LM. Neurol Sci. 2010.

De Mattos-Arruda L, et al. ctDNA from CSF vs plasma. Nat Commun. 2015.

Brastianos PK, et al. CSF sequencing in LM. Neuro Oncol. 2020.

Pentsova EI, et al. Next-gen sequencing of CSF in CNS cancers. JCO Precis Oncol. 2018.

Murthy RK, et al. HER2CLIMB trial. N Engl J Med. 2020.

Modi S, et al. DESTINY-Breast03 study. N Engl J Med. 2022.

Tolaney SM, et al. Abemaciclib in CNS metastases. Breast Cancer Res. 2020.

Emens LA, et al. Atezolizumab and nab-paclitaxel in TNBC. N Engl J Med. 2018.

Brastianos PK, et al. Nivolumab and ipilimumab in brain metastases. JAMA Oncol. 2020.

Groves MD. Role of radiotherapy in LM. Arch Neurol. 2010.

Brown PD, et al. Proton CSI in LM. J Clin Oncol. 2018.

Zagouri F, et al. Intrathecal trastuzumab in HER2+ breast cancer. Breast. 2013